Live feed17:45:33·410dINSIDERFilingvia QuantisnowChief Executive Officer Anzalone Christopher Richard was granted 340,000 shares and sold $774,975 worth of shares (51,425 units at $15.07), increasing direct ownership by 8% to 4,062,377 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.ARWR· Arrowhead Pharmaceuticals Inc.Health CareOriginal source
